SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
67 hedge funds and large institutions have $34.2M invested in Syros Pharmaceuticals, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 25 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
67
Holders Change
-27
Holders Change %
-28.72%
% of All Funds
1.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
17
Reduced
25
Closed
37
Calls
$2K
Puts
$10K
Net Calls
-$8K
Net Calls Change
-$27K
Top Buyers
1 |
Vanguard Group
Malvern,
Pennsylvania
|
$2.78M |
2 |
AG
Artal Group
Luxembourg
|
$3.85M |
3 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
$481K |
4 |
Millennium Management
New York
|
$928K |
5 |
E
Ergoteles
New York
|
$259K |